Private equity firm Advent-backed Bharat Serums and Vaccines (BSV) on Tuesday said it has acquired Tidilan (isoxsuprine hydrochloride), a leading brand in women’s health from Bengaluru-based Jagdale Industries. BSV...
Alembic Pharma buys out partner stake in Aleor Dermaceuticals
Alembic Pharmaceuticals on Tuesday said it has acquired the balance 40% stake in Aleor Dermaceuticals from its JV Partner Orbicular Pharmaceutical Technologies to strengthen its skin-related manufacturing and marketing...
Aurobindo Pharma buys Veritaz for Rs 171 crore to enter domestic formulation business
Drug maker Aurobindo Pharma on Monday said it has acquired the domestic formulations business of Veritaz for Rs 171 crore on debt free and cash-free basis. This acquisition vehicle will greatly help Aurobindo as a...
Sun to acquire Daiichi’s 11.28% stake in Zenotech
Sun Pharmaceutical Industries on Monday said it has entered into a share purchase agreement with Japan’s Daiichi Sankyo Company to acquire the latter’s 11.28% stake in Zenotech Laboratories. Sun Pharma said...
Blackstone closing in on Aurobindo’s injectables business
Blackstone has emerged as the frontrunner to acquire the wholly-owned injectables arm of Aurobindo Pharma, valuing the business at around ₹26,000-30,000 crore ($3.4-4 billion), making it arguably the largest deal in the...
Bharat Serums acquires 26 pc stake in solar power firm AMP Energy C&I One
Bharat Serums and Vaccines on Thursday said it has acquired a 26 per cent stake in AMP Energy C&I One to support green energy requirements for its manufacturing facility at Ambernath in Maharashtra. Aimed at driving...
BDR looking to buy majority stake in drug plant in Belarus
BDR Pharma, the Mumbai-based drugmaker that raised around ₹750 crore earlier this year from Renuka Ramnath-led private equity (PE) fund Multiples Alternate Asset Management, is gearing up for geographic expansion that...
SeQuent Scientific acquires Brazil-based animal drug firm for $5 million
PE firm Carlyle-backed SeQuent Scientific has acquired 100% stake in Brazil-based Nourrie Saúde e Nutrição Animal Ltd for $5 million (Rs 36.2 crore), via its wholly-owned subsidiary Alivira Animal Health. On December...
Mankind Pharma to acquire Panacea’s formulation brands for India, Nepal
Mankind Pharma on Monday said it will acquire Panacea Biotec Pharma’s formulations brands, for India and Nepal markets, for Rs 1,872 crore. Both the entities have entered into definitive agreements for the...
Biocon Biologics acquires Viatris’ biosimilar business for $3.34 billion
Biocon Biologics Ltd (BBL) the subsidiary of Biocon on Monday said it has entered into a definitive agreement to acquire Viatris’ biosimilars assets for $3.34 billion. Out of $3.34 billion, BBL will pay Viatris up to $2...
Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy’s Laboratories
Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy’s Laboratories to acquire two brands — Combihale and Daffy. While Combihale is used for the treatment of asthma and chronic obstructive...
Drugmaker Cipla to buy 32.49% stake in AMP Energy Green Eleven
Drug major Cipla said it has signed a pact to acquire 32.49 per cent stake in AMP Energy Green Eleven to set up a captive solar power project in Maharashtra. The company has entered into a shareholder’s agreement...
